Patents by Inventor Madison Tuttle

Madison Tuttle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Redox flow battery electrolytes with 2,5-dimercapto-1,3,4-thiadiazole (DMTD) and its derivatives
    Patent number: 11967747
    Abstract: The disclosed technology relates to redox flow batteries (“RFB”), and particularly to electrolytes useful in RFBs based on 2,5-dimercapto-1,3,4-thiadiazole (“DMTD”) and derivatives thereof.
    Type: Grant
    Filed: September 14, 2020
    Date of Patent: April 23, 2024
    Assignees: The Lubrizol Corporation, Ohio State Innovation Foundation
    Inventors: Shiyu Zhang, Paul E. Adams, Shelby Davis, Christopher Michael Rasik, Madison Tuttle
  • 2,5-Dimercapto-1,3,4-Thiadiazole (DMTD) Metal Salt Derivatives
    Publication number: 20230312496
    Abstract: The disclosed technology relates to 2,5-dimercapto-1,3,4-thiadiazole metal salts and electrolytes therewith for use in redox flow batteries.
    Type: Application
    Filed: August 23, 2021
    Publication date: October 5, 2023
    Inventors: Paul E. Adams, Shiyu Zhang, Christopher M. Rasik, Shelby Davis, Madison Tuttle, Ryan Richard Konrad
  • 2,5-Dimercapto-1,3,4-Thiadiazole (DMTD) Zinc Salt Derivatives
    Publication number: 20230312497
    Abstract: The disclosed technology relates to Zinc salts of 2,5-dimercapto-1,3,4-thiadiazole (“DMTD”), and electrodes therewith for use in zinc ion battery systems.
    Type: Application
    Filed: August 24, 2021
    Publication date: October 5, 2023
    Inventors: Paul E. Adams, Shiyu Zhang, Christopher M. Rasik, Madison Tuttle
  • REDOX FLOW BATTERY ELECTROLYTES WITH 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE (DMTD) AND ITS DERIVATIVES
    Publication number: 20220320561
    Abstract: The disclosed technology relates to redox flow batteries (“RFB”), and particularly to electrolytes useful in RFBs based on 2,5-dimercapto-1,3,4-thiadiazole (“DMTD”) and derivatives thereof.
    Type: Application
    Filed: September 14, 2020
    Publication date: October 6, 2022
    Inventors: Shiyu Zhang, Paul E. Adams, Shelby Davis, Christopher Michael Rasik, Madison Tuttle